Concord Biotech updates key managerial personnel for stock exchange disclosures

Concord Biotech Limited, a company listed on both the National Stock Exchange and BSE Limited, has revised its key managerial personnel (KMPs) authorized to make disclosures under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The updated list, effective December 18, 2025, now includes Sudhir Vaid as chairman and managing director, Ankur Vaid as joint managing director and chief executive officer, Raviraj Karia as chief financial officer, and Hina Patel as company secretary and compliance officer.

The announcement outlines that these individuals are responsible for determining the materiality of events and information and subsequently making the necessary disclosures to the stock exchanges. This modification aims to streamline the process of regulatory compliance and ensure timely and accurate dissemination of information to the market.

For any inquiries or further information regarding these disclosures, the company has provided contact details for its compliance officer. Hina Patel, in her capacity as company secretary and compliance officer, can be reached via email at complianceofficer@concordbiotech.com or by telephone at +079-68138700. The company's registered office is located in Ahmedabad, Gujarat.